SETD2 gene expression and the molecular landscape of colorectal cancer (CRC).

被引：0
|
作者：
Battaglin, Francesca
Krause, Harris
Elliot, Andrew
Abraham, Jim
Soni, Shivani
Algaze, Sandra
Jayachandran, Priya
Arai, Hiroyuki
Zhang, Wu
Lo, Jae Ho
Mittal, Pooja
Weinberg, Benjamin Adam
Lou, Emil
Shields, Anthony Frank
Goldberg, Richard M.
Goel, Sanjay
Marshall, John
Liang, Gangning
Korn, Wolfgang Michael
Lenz, Heinz-Josef
机构：
[1] USC Norris Comprehens Canc Ctr, Keck Sch Med, Div Med Oncol, Los Angeles, CA USA
[2] Caris Life Sci, Irving, TX USA
[3] Caris Life Sci, Phoenix, AZ USA
[4] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC USA
[5] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN USA
[6] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA
[7] West Virginia Univ, Inst Canc, Morgantown, WV USA
[8] West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV USA
[9] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[10] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
184
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [41] SETD2 LOSS CONTRIBUTES TO CHRONIC MYELOID LEUKEMIA PROGRESSION AFFECTING DNA INTEGRITY AND EPIGENETIC LANDSCAPE
    Mancini, M.
    De Santis, S.
    Monaldi, C.
    Bruno, S.
    Taccini, A. C.
    Castagnetti, F.
    Gugliotta, G.
    Iurlo, A.
    Cerrano, M.
    Galimberti, S.
    Balducci, S.
    Cavo, M.
    Soverini, S.
    HAEMATOLOGICA, 2024, 109 : 67 - 67
  • [42] SETD2 Loss Contributes to Chronic Myeloid Leukemia Progression Affecting DNA Integrity and Epigenetic Landscape
    Mancini, Manuela
    De Santis, Sara
    Monaldi, Cecilia
    Bruno, Samantha
    Mosca, Cristina
    Romagnoli, Lucia
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Iurlo, Alessandra
    Cerrano, Marco
    Galimberti, Sara
    Balducci, Serena
    Cavo, Michele
    Soverini, Simona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S366 - S367
  • [43] Evidences for mutations in the histone modifying gene SETD2 as critical drivers in leukemia development
    QianFei Wang
    Tao Cheng
    Science China Life Sciences, 2014, 57 : 944 - 946
  • [44] CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer
    Minh Nam Nguyen
    Choi, Tae Gyu
    Dinh Truong Nguyen
    Kim, Jin-Hwan
    Jo, Yong Hwa
    Shahid, Muhammad
    Akter, Salima
    Aryal, Saurav Nath
    Yoo, Ji Youn
    Ahn, Yong-Joo
    Cho, Kyoung Min
    Lee, Ju-Seog
    Choe, Wonchae
    Kang, Insug
    Ha, Joohun
    Kim, Sung Soo
    ONCOTARGET, 2015, 6 (31) : 31674 - 31692
  • [45] SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer
    Kumari, Subhadra
    Muthusamy, Srinivasan
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (06) : 556 - 564
  • [46] Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
    Lu, Mingdong
    Zhao, Bin
    Liu, Mengshan
    Wu, Le
    Li, Yingying
    Zhai, Yingna
    Shen, Xian
    NPJ PRECISION ONCOLOGY, 2021, 5 (01)
  • [47] Integrated multi-layer analysis reveals novel insights into the molecular landscape of colorectal cancer (CRC)
    Salvucci, Manuela
    Poynter, Liam
    Minerzami, Reza
    Carberry, Steven
    O'Byrne, Robert
    Cremona, Mattia
    Hennessy, Bryan T.
    Veselkov, Kirill
    Kinross, James
    Prehn, Jochen H.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] RECURRENT LOSS OF FUNCTION OF THE SETD2 GENE IN AGGRESSIVE SYSTEMIC MASTOCYTOSIS AND MAST CELL LEUKEMIA
    Soverini, S.
    Mancini, M.
    De Benedittis, C.
    Zazzeroni, L.
    Papayannidis, C.
    Guadagnuolo, V.
    Calogero, R.
    Zago, E.
    Scandola, A.
    Garonzi, M.
    Savini, P.
    Pagano, L.
    Zanotti, R.
    Perbellini, O.
    Bonadonna, P.
    Specchia, G.
    Merante, S.
    Elena, C.
    Gangemi, D.
    Grifoni, F. I.
    Ferrarini, A.
    Delledonne, M.
    Valent, P.
    Cavo, M.
    Rondoni, M.
    Martinelli, G.
    HAEMATOLOGICA, 2015, 100 : 110 - 111
  • [49] Molecular characterization of SETD2, a histone methyltransferase, in clear cell renal cell carcinoma (ccRCC)
    Thai Huu Ho
    Monzon, Federico A.
    Hoang, Anh
    Tamboli, Pheroze
    Furge, Kyle A.
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar M.
    Hung, Mien-Chie
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [50] Pan-cancer analysis of SETD2 mutation and its association with the efficacy of immunotherapy
    Mingdong Lu
    Bin Zhao
    Mengshan Liu
    Le Wu
    Yingying Li
    Yingna Zhai
    Xian Shen
    npj Precision Oncology, 5
12345